Protein Oxidation Products as Biomarkers

Area of Science:

• Biochemistry
• Pathology
• Gerontology

Background:

• Oxidative stress is implicated in aging, degenerative diseases, cellular damage, and mortality.
• Its precise contribution to clinical worsening and standardized measurement strategies remain unclear.
• Accumulation of oxidative damage to macromolecules is a key pathological mechanism.

Purpose of the Study:

• To review current methods for measuring oxidative stress in clinical settings.
• To highlight the challenges and limitations in objective oxidative stress determination.
• To identify promising strategies for reliable oxidative stress assessment.

Main Methods:

• Review of established and emerging methods for oxidative stress measurement.
• Analysis of techniques assessing lipid peroxidation (e.g., F2-isoprostanes, malondialdehyde).
• Evaluation of assays for DNA/RNA damage (e.g., 8-hydroxydesoxyguanosine) and protein oxidation (e.g., protein carbonyls, nitrotyrosine, HNE-modified proteins).

Main Results:

• Many oxidative stress measurement methods lack reliability and standardization for clinical use.
• Lipid peroxidation and DNA/RNA damage markers are widely accepted supportive parameters.
• Protein oxidation markers, particularly protein carbonyls, nitrotyrosine, and HNE-modified proteins, show increasing acceptance.
• Sample stability is a critical consideration for all clinical assays.

Conclusions:

• No single method can fully characterize oxidative stress in clinical conditions.
• Combining multiple damage parameters offers the most promising approach for reliable clinical assessment.
• Further research is needed to validate and standardize these combined methods.